首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.
【24h】

Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.

机译:预测系统性炎症反应综合征患者的死亡率:两种预后模型,两种可溶性受体和巨噬细胞迁移抑制因子的评估。

获取原文
获取原文并翻译 | 示例
       

摘要

Better outcomes in patients suspected of community-acquired infections requires the optimal and timely assessment of disease severity at the point of first contact with the health care system, which is typically in the emergency department. This study was conducted using a previously described, prospectively collected cohort of patients with systemic inflammatory response syndrome (SIRS) that were admitted to an emergency department and a department of infectious diseases at a university hospital. Plasma samples were collected and disease severity scores calculated upon admission. A multiplex immunoassay and a newly developed enzyme-linked immunosorbent assay (ELISA)-based assay were used to measure the soluble urokinase-type plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells-1, and macrophage migration inhibitory factor. The area under the receiver operating characteristic (ROC) curve for the prediction of 30- and 180-day mortality was used to compare the performance of the markers and the models. A total of 151 patients were eligible for analysis. Of these, nine died before day 30 and 19 died before day 180 post-admission. Admission-soluble urokinase-type plasminogen activator receptor levels were significantly higher in both day 30 and day 180 non-survivors. There was a non-significant trend towards higher macrophage migration inhibitory factor concentrations in day 30 non-survivors. Soluble triggering receptor expressed on myeloid cells-1 levels were significantly lower in non-survivors at both time points. The simplified acute physiology score II (SAPS II) and sequential organ failure assessment (SOFA) scores were significantly higher in non-survivors at both time points, indicating that these models intended for use in intensive care units might also be useful in an emergency department setting.
机译:在怀疑是社区获得性感染的患者中,要获得更好的结果,就需要在初次接触卫生保健系统(通常在急诊室)时,对疾病的严重程度进行最佳,及时的评估。这项研究是使用先前描述的,前瞻性收集的系统性炎症反应综合征(SIRS)患者队列进行的,这些患者被纳入大学医院的急诊科和传染病科。收集血浆样品并在入院时计算疾病严重程度评分。多重免疫测定和新开发的基于酶联免疫吸附测定(ELISA)的测定用于测量可溶性尿激酶型纤溶酶原激活剂受体,在髓样细胞-1上表达的可溶性触发受体和巨噬细胞迁移抑制因子。用来预测30天和180天死亡率的受试者工作特征(ROC)曲线下方的面积用于比较标记物和模型的性能。共有151名患者符合分析条件。其中,有9人在入院后第30天之前死亡,有19人在入院后第180天之前死亡。入院时可溶的尿激酶型纤溶酶原激活剂受体水平在第30天和第180天的非存活者中均显着较高。在第30天的非存活者中,巨噬细胞迁移抑制因子的浓度没有显着趋势。在两个时间点,非幸存者中髓样细胞-1水平表达的可溶性触发受体均显着降低。非幸存者在两个时间点的简化急性生理分数II(SAPS II)和连续器官衰竭评估(SOFA)分数均显着较高,这表明这些打算用于重症监护病房的模型在急诊科中也可能有用设置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号